Page last updated: 2024-10-22

albuterol and Allergic Bronchopulmonary Aspergilloses

albuterol has been researched along with Allergic Bronchopulmonary Aspergilloses in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, JM1
Mak, G1
Shaw, J1
Porter, P1
McDermott, C1
Roberts, L1
You, R1
Yuan, X1
Millien, VO1
Qian, Y1
Song, LZ1
Frazier, V1
Kim, C1
Kim, JJ1
Bond, RA1
Milner, JD1
Zhang, Y1
Mandal, PK1
Luong, A1
Kheradmand, F1
McMurray, JS1
Corry, DB1

Other Studies

1 other study available for albuterol and Allergic Bronchopulmonary Aspergilloses

ArticleYear
Long-Acting Beta Agonists Enhance Allergic Airway Disease.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anti-Asthmatic Agents; Arrestins; Aspergill

2015